Degenerative Spinal Arthritis Management
Initial Therapy and NSAID Selection
- The American College of Rheumatology recommends starting with paracetamol (acetaminophen) up to 4 g daily as first-line treatment, and if paracetamol fails to provide adequate symptom relief, proceed to ibuprofen 1.2 g daily as first-line NSAID therapy for degenerative spinal arthritis, due to its lowest gastrointestinal risk profile among NSAIDs while providing effective pain relief 1
- Ibuprofen is designated as the lowest risk NSAID for serious gastrointestinal complications compared to all other NSAIDs, based on 12 controlled epidemiological studies examining 14 different NSAIDs 1
Safety Profile Considerations
- The gastrointestinal risk hierarchy for NSAIDs is: ibuprofen (lowest risk) at doses ≤1.2 g daily, intermediate risk for diclofenac, naproxen, and high-dose ibuprofen (2.4 g), and highest risk for azapropazone 1
- The American Heart Association and other organizations suggest basing NSAID selection on GI risk factors, such as history of ulcers, age >65, concurrent anticoagulation, and corticosteroid use 2, 3, 4, 5
GI Protection Strategy
- For patients requiring NSAIDs with GI risk factors, misoprostol reduces serious upper GI complications with a number needed to treat (NNT) of 264 over 6 months, and proton pump inhibitors are equally effective as misoprostol for preventing NSAID-induced ulcers and are better tolerated 1
- H2 blockers reduce duodenal ulcer risk with long-term use 1